Journal article · 2021 · Open access

Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice

Naoto Haruyama, Takayoshi Yamaza, Shigeki Suzuki, Bradford Hall, Andrew Cho, Carolyn W. Gibson, Ashok B. Kulkarni

PLoS ONE, 16(11), e0259966 · Published 15 November 2021 · DOI 10.1371/journal.pone.0259966

Open PDFView at the publisherCite this paper

In brief

“Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice” is a 2021 journal article by Naoto Haruyama and 6 co-authors, published in PLoS ONE. OpenAlex counts 6 citations as of 18 November 2026, which puts it in the top 9% of works published in 2021 by citations. It is open access under a public domain licence: the full text is free to read at PLoS ONE.

Citations
6
Most cited in
2022 (2)
Field-weighted impact
0.26
References
60
Authors
7

Abstract

Amelogenins, major extra cellular matrix proteins of developing tooth enamel, are predominantly expressed by ameloblasts and play significant roles in the formation of enamel. Recently, amelogenin has been detected in various epithelial and mesenchymal tissues, implicating that it might have distinct functions in various tissues. We have previously reported that leucine rich amelogenin peptide (LRAP), one of the alternate splice forms of amelogenin, regulates receptor activator of NF-kappa B ligand (RANKL) expression in cementoblast/periodontal ligament cells, suggesting that the amelogenins, especially LRAP, might function as a signaling molecule in bone metabolism. The objective of this study was to identify and define LRAP functions in bone turnover. We engineered transgenic (TgLRAP) mice using a murine 2.3kb α1(I)-collagen promoter to drive expression of a transgene consisting of LRAP, an internal ribosome entry site (IRES) and enhanced green fluorescent protein (EGFP) to study functions of LRAP in bone formation and resorption. Calvarial cell cultures from the TgLRAP mice showed increased alkaline phosphatase (ALP) activity and increased formation of mineralized nodules compared to the cells derived from wild-type (WT) mice. The TgLRAP calvarial cells also showed an inhibitory effect on osteoclastogenesis in vitro. Gene expression comparison by quantitative polymerase chain reaction (Q-PCR) in calvarial cells indicated that bone formation makers such as Runx2, Alp, and osteocalcin were increased in TgLRAP compared to the WT cells. Meanwhile, Rankl expression was decreased in the TgLRAP cells in vitro. The ovariectomized (OVX) TgLRAP mice resisted bone loss induced by ovariectomy resulting in higher bone mineral density in comparison to OVX WT mice. The quantitative analysis of calcein intakes indicated that the ovariectomy resulted in increased bone formation in both WT and TgLRAP mice; OVX TgLRAP appeared to show the most remarkably increased bone formation. The parameters for bone resorption in tissue sections showed increased number of osteoclasts in OVX WT, but not in OVX TgLRAP over that of sham operated WT or TgLRAP mice, supporting the observed bone phenotypes in OVX mice. This is the first report identifying that LRAP, one of the amelogenin splice variants, affects bone turnover in vivo.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Haruyama, N., Yamaza, T., Suzuki, S., Hall, B., Cho, A., Gibson, C. W., & Kulkarni, A. B. (2021). Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice. PLoS ONE, 16(11), e0259966. https://doi.org/10.1371/journal.pone.0259966

MLA 9

Haruyama, Naoto, et al. “Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice.” PLoS ONE, vol. 16, no. 11, 2021, p. e0259966. https://doi.org/10.1371/journal.pone.0259966.

Chicago

Haruyama, Naoto, Takayoshi Yamaza, Shigeki Suzuki, Bradford Hall, Andrew Cho, Carolyn W. Gibson, and Ashok B. Kulkarni. 2021. “Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice.” PLoS ONE 16 (11): e0259966. https://doi.org/10.1371/journal.pone.0259966.

Harvard

Haruyama, N. et al. (2021) ‘Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice’, PLoS ONE, 16(11), p. e0259966. doi:10.1371/journal.pone.0259966.

IEEE

N. Haruyama et al., “Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice,” PLoS ONE, vol. 16, no. 11, p. e0259966, 2021, doi: 10.1371/journal.pone.0259966.

BibTeX

@article{haruyama2021leucine,
  title     = {{Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice}},
  author    = {Haruyama, Naoto and Yamaza, Takayoshi and Suzuki, Shigeki and Hall, Bradford and Cho, Andrew and Gibson, Carolyn W. and Kulkarni, Ashok B.},
  journal   = {PLoS ONE},
  year      = {2021},
  volume    = {16},
  number    = {11},
  pages     = {e0259966},
  doi       = {10.1371/journal.pone.0259966},
  url       = {https://doi.org/10.1371/journal.pone.0259966}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202222
202422
202511
202611

Its field-weighted citation impact is 0.26: it has been cited 0.26 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases

  • ovariectomy-induced bone loss
  • bone turnover
  • bone formation
  • bone resorption
  • osteoclastogenesis
  • RANKL expression
  • transgenic mice
  • calvarial cells

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Haruyama, N., Yamaza, T., Suzuki, S., Hall, B., Cho, A., Gibson, C. W., & Kulkarni, A. B. (2021). Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice. PLoS ONE, 16(11), e0259966. https://doi.org/10.1371/journal.pone.0259966

How many times has this paper been cited?

6 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at PLoS ONE: sign in and open the PDF from this page.

Who wrote this paper?

Naoto Haruyama, Takayoshi Yamaza, Shigeki Suzuki, Bradford Hall, Andrew Cho, Carolyn W. Gibson, Ashok B. Kulkarni.

What is the DOI of this paper?

10.1371/journal.pone.0259966, permanently at https://doi.org/10.1371/journal.pone.0259966. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.